BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37675711)

  • 21. Lymph node metastases in paediatric and young adult patients with non-rhabdomyosarcoma soft tissue sarcoma (NRSTS): Findings from Children's Oncology Group (COG) study ARST0332.
    Alvarez E; He J; Spunt SL; Hayes-Jordan A; Kao SC; Parham DM; Million L; Weiss AR; Barkauskas DA
    Eur J Cancer; 2023 Feb; 180():89-98. PubMed ID: 36566574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Joshi D; Anderson JR; Paidas C; Breneman J; Parham DM; Crist W;
    Pediatr Blood Cancer; 2004 Jan; 42(1):64-73. PubMed ID: 14752797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical analysis of 51 cases with rare childhood soft tissue sarcomas].
    Cai MX; Pan C; Ye QD; Zhou M; Gao YJ; Hu WT; Tang JY
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):917-922. PubMed ID: 27938592
    [No Abstract]   [Full Text] [Related]  

  • 24. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Harrison DJ; Qumseya A; Xue W; Arnold M; Lautz TB; Hiniker SM; Thomas SM; Venkatramani R; Weiss AR; Mascarenhas L
    Pediatr Blood Cancer; 2024 Apr; 71(4):e30847. PubMed ID: 38282125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).
    Brennan B; Zanetti I; Orbach D; Gallego S; Francotte N; Van Noesel M; Kelsey A; Casanova M; De Salvo GL; Bisogno G; Ferrari A
    Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localized unresectable non-rhabdo soft tissue sarcomas of the extremities in pediatric age: results from the Italian studies.
    Cecchetto G; Alaggio R; Dall'Igna P; Bisogno G; Ferrari A; Gigante C; Casanova M; Sotti G; Zanetti I; Carli M
    Cancer; 2005 Nov; 104(9):2006-12. PubMed ID: 16161038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
    Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric sarcoma in Central America: outcomes, challenges, and plans for improvement.
    Friedrich P; Ortiz R; Strait K; Fuentes S; Gamboa Y; Arambú I; Ah-Chu-Sanchez M; London W; Rodríguez-Galindo C; Antillón-Klussmann F; Báez F;
    Cancer; 2013 Feb; 119(4):871-9. PubMed ID: 22972687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open-label, multicentre, randomised, phase II study of the EpSSG and the ITCC evaluating the addition of bevacizumab to chemotherapy in childhood and adolescent patients with metastatic soft tissue sarcoma (the BERNIE study).
    Chisholm JC; Merks JHM; Casanova M; Bisogno G; Orbach D; Gentet JC; Thomassin-Defachelles AS; Chastagner P; Lowis S; Ronghe M; McHugh K; van Rijn RR; Hilton M; Bachir J; Fürst-Recktenwald S; Geoerger B; Oberlin O;
    Eur J Cancer; 2017 Sep; 83():177-184. PubMed ID: 28738258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
    Raney RB; Asmar L; Vassilopoulou-Sellin R; Klein MJ; Donaldson SS; Green J; Heyn R; Wharam M; Glicksman AS; Gehan EA; Anderson J; Maurer HM
    Med Pediatr Oncol; 1999 Oct; 33(4):362-71. PubMed ID: 10491544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of metastatic non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) treated within the BERNIE study: a randomised, phase II study evaluating the addition of bevacizumab to chemotherapy.
    Ferrari A; Merks JHM; Chisholm JC; Orbach D; Brennan B; Gallego S; van Noesel MM; McHugh K; van Rijn RR; Gaze MN; Martelli H; Bergeron C; Corradini N; Minard-Colin V; Bisogno G; Geoerger B; Caron HN; De Salvo GL; Casanova M
    Eur J Cancer; 2020 May; 130():72-80. PubMed ID: 32179448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of soft tissue sarcomas in 1118 cases.
    Fang ZW; Chen J; Teng S; Chen Y; Xue RF
    Chin Med J (Engl); 2009 Jan; 122(1):51-3. PubMed ID: 19187617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soft-tissue sarcomas of the diaphragm: a report from the Intergroup Rhabdomyosarcoma Study Group from 1972 to 1997.
    Raney RB; Anderson JR; Andrassy RJ; Crist WM; Donaldson SS; Maurer HM;
    J Pediatr Hematol Oncol; 2000; 22(6):510-4. PubMed ID: 11132218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonrhabdomyosarcoma soft tissue sarcomas in children: is age at diagnosis an important variable?
    Hayes-Jordan AA; Spunt SL; Poquette CA; Cain AM; Rao BN; Pappo AS; Shochat SJ
    J Pediatr Surg; 2000 Jun; 35(6):948-53; discussion 953-4. PubMed ID: 10873042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric soft tissue sarcoma of the limbs: clinical outcome of 97 patients.
    Sambri A; Bianchi G; Cucurnia I; Gambarotti M; Donati DM
    Eur J Orthop Surg Traumatol; 2018 Jan; 28(1):1-7. PubMed ID: 28766068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and outcomes of extremity soft-tissue sarcomas in children.
    Cheung MC; Zhuge Y; Yang R; Ogilvie MP; Koniaris LG; Rodríguez MM; Sola JE
    J Surg Res; 2010 Oct; 163(2):282-9. PubMed ID: 20638678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.
    Cormier JN; Patel SR; Herzog CE; Ballo MT; Burgess MA; Feig BW; Hunt KK; Raney RB; Zagars GK; Benjamin RS; Pisters PW
    Cancer; 2001 Sep; 92(6):1550-5. PubMed ID: 11745234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
    Devadas SK; Banavali S
    Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas: Standard of Care and Treatment Recommendations from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
    Ferrari A; Brennan B; Casanova M; Corradini N; Berlanga P; Schoot RA; Ramirez-Villar GL; Safwat A; Guillen Burrieza G; Dall'Igna P; Alaggio R; Lyngsie Hjalgrim L; Gatz SA; Orbach D; van Noesel MM
    Cancer Manag Res; 2022; 14():2885-2902. PubMed ID: 36176694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soft-tissue sarcomas other than rhabdomyosarcoma in children.
    Hayani A; Mahoney DH; Hawkins HK; Steuber CP; Hurwitz R; Fernbach DJ
    Med Pediatr Oncol; 1992; 20(2):114-8. PubMed ID: 1734215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.